Skip to content

Clinical trials

Phase 3 Asthma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 3 Country / region: South Korea Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20102
20112
20125
20135
20148
20155
20163
20173
20181
20193
20201
20221
20238
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated6
Recruiting5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca21
GlaxoSmithKline12
Areteia Therapeutics4
Boehringer Ingelheim3
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Sanofi2
Teva Branded Pharmaceutical Products R&D, Inc.2
Generate Biomedicines1
Hanmi Pharmaceutical Company Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma53
Pulmonary Eosinophilia7
Lung Diseases6
Lung Diseases, Obstructive6
Respiratory Tract Diseases6
Bronchial Diseases5
Churg-Strauss Syndrome1
Hypereosinophilic Syndrome1
Rhinitis, Allergic1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.